Prescription medication · Antidiarrheal Combination
diphenoxylate/atropine
Also sold as Lomotil. Lomotil is used to treat diarrhea in people 13 years and older.
Data updated 2026-05-15
- 1
- InteractionFew interactions
- $2.89
- Brand price (NADAC)
diphenoxylate/atropine (Lomotil) is a prescription Antidiarrheal Combination. Lomotil is used to treat diarrhea in people 13 years and older.
Lomotil is a drug that helps manage diarrhea. It contains two medicines, diphenoxylate and atropine, to slow down your bowels.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$2.89/unit
Generic Available
No
PFIZER
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
What it does
Lomotil is used to treat diarrhea in people 13 years and older.
Common side effects
Numbness in your arms and legs, Feeling of well-being, Depression
Key warnings
Lomotil can cause serious side effects, including breathing problems and nervous system issues.
The sections below are summarized in plain English from diphenoxylate/atropine's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Lomotil works by slowing down the movement of your intestines. Diphenoxylate reduces bowel contractions. Atropine is added to discourage people from taking too much of this medicine.
Serious Warnings
Lomotil can cause serious side effects, including breathing problems and nervous system issues. Dehydration and electrolyte imbalance can also occur. If you have an infection causing your diarrhea, Lomotil can make it worse. Do not use if you are under 6 years old.
Known Drug Interactions
Other Drugs that Cause CNS Depression The concurrent use of Lomotil with other drugs that cause CNS depression (e.g., barbiturates, benzodiazepines, opioids, buspirone, antihistamines, muscle relaxants), may potentiate the effects of Lomotil (see WARNINGS ).
Mechanism: Both of these medicines can slow down the central nervous system, and taking them together can make these drowsy effects much stronger.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Who should not take Lomotil?
Can I drink alcohol while taking Lomotil?
What should I do if Lomotil doesn't improve my diarrhea?
Can Lomotil cause constipation?
Can I take Lomotil with other medications?
What are the signs of an overdose?
How quickly does Lomotil work?
Can Lomotil cause allergic reactions?
Is Lomotil a cure for diarrhea?
What if I am taking an MAOI?
What are the common side effects of diphenoxylate/atropine?
Does diphenoxylate/atropine interact with other medications?
What drug class is diphenoxylate/atropine?
What pregnancy or breastfeeding source fields are listed for diphenoxylate/atropine?
Related Medications in Antidiarrheal Combination
Other drugs grouped near diphenoxylate/atropine - same-class peers and common alternatives.
alosetron
Lotronex
Alosetron (Lotronex) is a medicine for women with severe diarrhea-predominant irritable bowel syndrome (IBS).
Compare with diphenoxylate/atropine →
aprepitant
Emend
Aprepitant (Emend) is a medicine that helps prevent nausea and vomiting.
Compare with diphenoxylate/atropine →
bisacodyl
Dulcolax
Bisacodyl is a medicine that helps you have a bowel movement.
Compare with diphenoxylate/atropine →
bismuth subsalicylate
Pepto-Bismol
Bismuth subsalicylate (Pepto-Bismol) is a medicine that can treat diarrhea and upset stomach.
Compare with diphenoxylate/atropine →
cimetidine
Tagamet
Cimetidine (Tagamet) reduces stomach acid.
Compare with diphenoxylate/atropine →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on diphenoxylate/atropine
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for diphenoxylate/atropine
The FDA label for diphenoxylate/atropine (sold under brand names such as Lomotil) classifies it as a prescription-only medication in the Antidiarrheal Combination class. Lomotil is used to treat diarrhea in people 13 years and older. Official labeling lists 9 commonly reported side effects, including Numbness in your arms and legs, Feeling of well-being, Depression.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. The database also lists 1 documented drug interaction derived from FDA labeling, with the top-flagged interaction rated minor severity. NADAC pricing from CMS.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: April 3, 2025
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages